CENTRICSBIO, INC.

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2025-09-18

Patent Grants:

Last grant date:

2026-05-05

Top Inventors for applications by CENTRICSBIO, INC.

These are the the leading inventors for applications assigned to CENTRICSBIO, INC.:

Suin LEE 2 Guri-si, South Korea
Jaewon JEON 2 Suwon-si,, South Korea
Jae-won Jeon 2 Seoul, South Korea
Joon-Goo JUNG 2 Sejong-Si, South Korea

Haneul KIM 2 Namyangju-si, South Korea
Jae-Won JEON 1 Suwon-si, South Korea
Sunwha Kim 1 Seoul, South Korea
Suin LEE 1 Gunpo-si, Gyeonggi-do, South Korea

Haneul KIM 1 Namyangju-si, Gyeonggi-do, South Korea
Chang Ki LIM 1 Hwaseong-si, Gyeonggi-do, South Korea
Jae-Won JEON 1 Suwon-si, Gyeonggi-do, South Korea
Suin LEE 1 Gunpo-si, South Korea

Jongyeob Kim 1 Seoul, South Korea
Woochang KIM 1 Chuncheon-si, South Korea

Recent patent applications by CENTRICSBIO, INC.

CENTRICSBIO, INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-09-18

US20250289886A1

Chemistry; metallurgy

ANTI-CD300C ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USES THEREOF FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASE

#2 | 2024-11-07

US20240368599A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING CD300C EXPRESSION INHIBITOR OR ACTIVITY INHIBITOR

#3 | 2024-08-01

US20240254220A1

Chemistry; metallurgy

COMBINED THERAPY USING ANTI-CD300C ANTIBODY

#4 | 2022-09-29 ✅ Patent 12,616,734 granted on 2026-05-05

US20220305082A1

Human necessities

CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY BINDING TO CD 300C ANTIGEN OR RECEPTOR THEREOF

#5 | 2022-09-01

US20220275103A1

Chemistry; metallurgy

ANTI-CD300C MONOCLONAL ANTIBODY AND BIOMARKER THEREOF FOR PREVENTING OR TREATING CANCER

#6 | 2021-08-05

US20210238596A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING CD300C EXPRESSION INHIBITOR OR ACTIVITY INHIBITOR

Also check out CentricsBio, Inc.'s (Seoul, South Korea) applicant profile with 4 patent applications submitted.

AssigneeID:

313579 ⎘